P157 MammaPrint 8-year follow up results in patients with early breast cancer from a single-center Italian cohort study
Main Authors: | E. Fiorino, F. Giudici, S. Aguggini, C. Strina, M. Milani, N. Ziglioli, M. Dester, G. Barbieri, M. Alberio, C. Azzini, G. Ferrero, M. Ungari, C. Dreezen, D. Pronin, D. Generali |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623002746 |
Similar Items
-
Prognostic Value of MammaPrint in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-01-01) -
Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer
by: Inès J. Beumer, et al.
Published: (2016-12-01) -
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
by: Hatem Soliman, et al.
Published: (2020-01-01) -
5-yr DMFS outcomes on the pre-operative use of MammaPrint and BluePrint for neoadjuvant decisions in the NBREaST II trial
by: E. Göker, et al.
Published: (2021-04-01) -
P015 Breast Cancer patient selection for Extended Endocrine Therapy in the IDEAL trial by the 70-gene MammaPrint Test can prevent overtreatment and associated adverse events
by: G.-J. Liefers, et al.
Published: (2023-03-01)